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Abstract A potent actinobacterial strain isolated from the
marine samples of Bheemunipatnam beach, Visakhapat-
nam, India, was identified as Rhodococcus sp. VLD-10
using the conventional and genomic (16S rRNA) approa-
ches. Bioactive compounds responsible for the antimicro-
bial activity of the strain were elucidated by cultivating the
strain VLD-10 in a modified yeast extract-malt extract-
lactose broth followed by subsequent chromatographic and
spectroscopic analyses. Extraction, purification, and struc-
tural confirmation of five compounds, viz., benzoic acid,
2-nitrobenzaldehyde, 4-chlorobenzaldehyde, nonadeconoic
acid, and 3-isopropylhexahydro-1H-pyrido[1,2-a] pyr-
azine-1,4(6H)-dione, from Rhodococcus sp. VLD-10 were
fruitfully described. The bioactivity of the compounds
isolated from the strain VLD-10 against Gram-positive as
well as Gram-negative bacteria, yeast, and molds was
tested and their minimum inhibition concentration was
reported. Antibacterial activity of 3-isopropylhexahydro-
1H-pyrido[1,2-a] pyrazine-1,4(6H)-dione is more promi-
nent against Bacillus subtilis, B. cereus, B. megaterium,
Corynebacterium diphtheriae, and Escherichia coli,
whereas its antifungal spectrum showed less potency
against yeast and fungi. This is the first report on the nat-
ural occurrence and bioactivity of 3-isopropylhexahydro-
1H-pyrido[1,2-a] pyrazine-1,4(6H)-dione from Rhodococ-
cus sp. VLD-10.




Microorganisms are capable of carrying out a tremendous
variety of reactions and can adapt to a range of environ-
ments allowing them to be transplanted from nature to the
laboratory where they can be grown on inexpensive carbon
and nitrogen sources to produce valuable compounds
(Narayana and Vijayalakshmi 2008; Manivasagan et al.
2013). Because of their biological activity, secondary
metabolites of microbial origin are extremely important to
our health and nutrition, and have a tremendous economic
importance. The screening of microbial natural products
continues to represent an important route to the discovery
of novel chemicals, for development of new therapeutic
agents and for evaluation of the potential of lesser-known
or new bacterial taxa (Kurtboke and Wildman 1998;
Ramesh and William 2012). Natural products or their
derivatives remain the most significant source of novel
medicines (Newman et al. 2003; Fenical 2006; Lam 2007;
Manivasagan et al. 2013). Among the potential sources of
natural products, bacteria are proven to be a predominantly
prolific resource with a surprisingly small group of taxa
accounting for the vast majority of compounds discovered
(Keller and Zengler 2004). Among them, bacteria belong-
ing to the order Actinomycetales (commonly called
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actinobacteria) are distributed ubiquitous in nature and
account for more than 50% of the compounds reported in
the Dictionary of Natural Products.
In world’s 70% water ecosystem, Indian marine envi-
ronment is believed to have rich microbial diversity.
However, the wealth of indigenous marine microflora has
not been fully explored. Most of the studies on marine
microorganisms have been limited to isolation, identifica-
tion, and maintenance of these organisms on different
culture media. Their biotechnological potentials are yet to
be fully explored (Sivakumar et al. 2007; Manivasagan
et al. 2013). East Coast of India is reported to be a major
source of actinobacteria (Sambamurthy and Ellaiah 1974;
Balagurunathan 1992; Dhanasekaran et al. 2005;
Vijayakumar et al. 2007). Therefore, there is tremendous
scope to identify new or rare marine microorganisms from
this region and also to discover novel microbial metabolites
with diverse biological activities (Dhanasekaran et al.
2005; Ramesh and Mathivanan 2009; Ramesh and William
2012). The recent discovery of novel secondary metabo-
lites from taxonomically unique populations of marine
actinobacteria suggested that these bacteria add an impor-
tant new dimension to microbial natural product research.
Continued efforts to characterize marine actinobacterial
diversity and how adaptations to the marine environment
affect secondary metabolite production will create a better
understanding of the potential utility of these bacteria as a
source of useful products for biotechnology (Jensen et al.
2015). These findings will hopefully encourage additional
studies addressing the ecological roles of actinobacteria in
the marine environment, their diversity, distribution, cul-
ture requirements, and evolutionary responses to life in the
sea. In view of the significance of marine actinobacteria as
potential producers of bioactive compounds, this study is
mainly aimed to identify the potent strain, Rhodococcus sp.
VLD-10, isolated from marine soil samples of Bheemili
beach, Visakhapatnam, India, and to characterize the
bioactive metabolites responsible for its antimicrobial
activity.
Materials and methods
Isolation and identification of an actinobacterial
strain VLD-10
An actinobacterial strain, VLD-10, was isolated from
marine samples collected at a depth of 5–10 cm from
Bheemunipatnam beach, Visakhapatnam, India, in sterile
polyethylene bags. The soil dried at 45 C for 1 h in hot air
oven was pretreated with calcium carbonate (1:1 w/w)
followed by plating on YMD agar medium using soil
dilution technique (Williams and Cross 1971).
Taxonomic studies of the actinobacterial strain
VLD 10
Cultural, physiological, and morphological characteristics
together with genomic (16S rDNA gene sequencing)
analysis of the strain were studied.
The growth characteristics of the strain were studied on
seven International Streptomyces Project (ISP) media, such
as ISP-1 (Tryptone-yeast extract agar), ISP-2 (Yeast
extract-malt extract-dextrose agar), ISP-3 (Oat meal agar),
ISP-4 (Inorganic salts starch agar), ISP-5 (Glycerol-as-
paragine salts agar), ISP-6 (Peptone yeast extract iron agar
medium), and ISP-7 (Tyrosine agar), as well as on five
nonISP media, such as Nutrient agar (NA), Czapek–Dox
(CD) agar, Bennett’s agar, Glucose–tryptone (GT) agar,
and Starch casein (SC) agar, with the initial pH 7.2
maintained at 30 C (Dietz and Theyer 1980). Cultural
characters, such as growth, color of the aerial and substrate
mycelia, and pigment production, were observed. Physio-
logical and biochemical tests of the strain were examined
using standard protocols (Shirling and Gottlieb 1966).
Slide culture technique was employed to study the
micro-morphology of the strain cultured on ISP-2 medium.
The detailed micro-morphology of the strain was recorded
using Scanning Electron Microscopy (SEM) as previously
described (Bozzola and Russell 1999). The culture was
fixed in 2.5% glutaraldehyde prepared in 0.1 M phosphate
buffer (pH 7.2) for 24 h at 4 C followed by the post-
fixation step in 2% aqueous osmium tetroxide for 4 h in the
same buffer. The sample was then dehydrated in ethanol
and then dried up to critical with the help of Electron
Microscopy Science CPD unit (Ruska Labs, Acharya N.
G. Ranga Agricultural University, Hyderabad, India). The
dried sample was mounted on aluminum stubs covered
with double-sided carbon tape. A thin layer of gold coating
was applied over the sample using automated sputter
coaster for 3 min (JEOL JFC-1600, Japan). Finally, the
samples were examined under SEM at various magnifica-
tions (Model: JOEL-JSM 5600, Japan).
Molecular identification of the strain based on 16S
rDNA sequence analysis
The strain grown inYMDbroth for 3 dayswas centrifuged at
10,000 rpm for 20 min and the pellet was used for the
extraction of DNA (Mehling et al. 1995). PCR mixture
consisted of 2.5 ll of 10X Taq buffer, 3.5 ll of MgCl2
(25 mM), 2 ll of dNTP (0.4 mM), 1 ll of 16S rDNA for-
ward primer—50-CCCATG TTGGGTATTCCTCCAGGC-
GAAAACGGG 30 (10 pmol/ll), 1 ll of 16S rDNA reverse
primer—50CCCGCATTATCCGTACTCCCCAGGCGGG
GC-30 (10 pmol/ll), Taq polymerase (2 U/ll), and 2 ll
template DNA. PCR amplification was carried out as
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follows: the initial denaturation step at 94 C for 3 min
followed by 30 cycles of denaturation at 94 C for 1 min,
annealing at 65 C for 1 min, and extension at 72 C for
1 min, with a further 5 min extension at 72 C. The PCR
product was purified with agarose gel DNA purification kit
(SoluteReady Genomic DNA purification kit, HELINI
Biomolecules, Chennai, India) followed by sequencing of
750 bp. The deduced partial 16S rDNA gene sequence was
compared with the accessible sequences in GenBank (http://
www.ncbi.nlm.nih.gov/) using Basic Local Alignment
Search Tool (BLAST) in NCBI GenBank databases. Phy-
logenetic and molecular evolutionary analyses were con-
ducted using Molecular Evolutionary Genetic Analysis
(MEGA) version 4.0 (Tamura et al. 2007).
Extraction, purification, and structural confirmation
of bioactive compounds produced by Rhodococcus
sp. VLD-10
Production of bioactive metabolites
For the large-scale production of bioactive compounds
from the strain, 10% of seed broth was inoculated into the
optimized production medium (lactose @ 10 g, yeast
extract @ 10 g, malt extract @ 10 g, and sodium chloride
@ 60 g dissolved in 1 L distilled water and adjusted to pH
7.0) for the enhanced secondary metabolite production.
The fermentation was carried out in 1 L Roux bottles for
120 h at 30 C.
Isolation, purification, and identification of bioactive
compounds
The bioactive compounds from the fermented broth were
harvested by filtration of biomass through Whatman filter
paper no. 42 (Merck, Mumbai, India). The culture filtrate
(25 L) was extracted twice with an equal volume of ethyl
acetate and pooled, and the organic layer was concentrated
in a Rotovac. The deep brown semi-solid compound (3.8 g)
obtained was applied to a silica gel G column
(80 9 2.5 cm, Silica gel, Merck, Mumbai, India).
The separation of the crude extract was conducted via
gradient elution with hexane: ethyl acetate. The eluent was
run over the column and small volumes of eluent collected
in test tubes were analyzed via thin-layer chromatography
(TLC) using silica gel plates (Silica gel, Merck, Mumbai,
India) with hexane: ethyl acetate solvent system. Com-
pounds with identical retention factors (Rf) were combined
and assayed for antimicrobial activities. The crude eluent
was recuperated in 5–10 ml of ethyl acetate and was fur-
ther purified.
Among the 11 main fractions eluted, 10 fractions
were found polar and 1 was nonpolar residue.
Antimicrobial activity was tested for all the fractions
obtained. Among the 10 polar fractions eluted from the
crude extract, three fractions along with the nonpolar
fraction exhibited high antimicrobial activity. D1 (70–30
v/v), D2 (30–70 v/v), D3 (20–80 v/v), and D4 (100–0
v/v) were the fractions collected at different hexane:
ethyl acetate solvent system. All the fractions were
rechromatographed using different gradient eluent sys-
tems for final elucidation of compounds. The fraction D1
on further purification yielded two compounds each in
pure form (D1Ba and D1Bb). The second fraction D2
also yielded two subfractions in pure form namely D2Ba
and D2Bb. The fraction D3 was single and obtained in
pure form. The structure of these active fractions was
analyzed on the basis of Fourier Transform Infrared
(FTIR); model: Thermo Nicolet Nexus 670 spectropho-
tometer with NaCl optics, Electron Ionization Mass/
Electron Spray Ionization Mass Spectrophotometry
(EIMS/ESIMS); model: Micromass VG-7070H, 70 eV
spectrophotometer and Nuclear Magnetic Resonance (1H
NMR and 13C NMR); and model: Varian Gemini 200,
and samples were made in CDCl3 with trimethyl silane
as standard.
Determination of minimum inhibitory concentration
(MIC) of bioactive compounds
The antimicrobial spectra of the bioactive compounds
produced by the strain were determined in terms of
minimum inhibitory concentration (MIC) against a wide
variety of Gram-positive, Gram-negative bacteria, and
fungi using agar plate diffusion assay (Cappuccino and
Sherman 2002). Nutrient agar and Czapek–Dox agar
were the media prepared for the growth of bacteria and
fungi, respectively. The metabolite dissolved in DMSO
at concentrations ranging from 0 to 1000 lg/ml was used
to assay against the test bacteria, such as B. cereus
(MTCC 430), B. megaterium (NCIM 2187), B. subtilis
(MTCC 441), Corynebacterium diphtheriae (MTCC
116), E. coli (MTCC 40), Pseudomonas aeruginosa
(MTCC 424), Salmonella typhi (ATCC 14028), Serratia
marcescens (MTCC 118), Shigella flexneri (MTCC
1457), Staphylococcus aureus (MTCC 96), Xanthomonas
campestris (NCIM 2310), and fungi, including Asper-
gillus niger (ATCC 1015), Alternaria alternata (MTCC
6572), Botrytis cinerea, C. albicans (MTCC 183),
Fusarium oxysporum (MTCC 218), F. solani (MTCC
4634), and Verticillium alboatrum. The inoculated plates
were examined after 24–48 h of incubation at 37 C for
bacteria and 48–72 h at 28 C for fungi. The lowest
concentration of the bioactive metabolite exhibiting
significant antimicrobial activity against the test
microbes was taken as the MIC of the compound.
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Results and discussion
Isolation and identification of an actinobacterial
strain VLD-10
An actinobacterial strain, VLD-10, isolated from marine
samples of Bheemunipatnam beach, Visakhapatnam, India,
was purified on YMD agar medium using classical
microbiological methods. Taxonomic position of the strain
was described on the basis of cultural, morphological,
physiological, and genomic analyses.
Cultural characteristics of the strain were studied by
growing the isolate on seven ISP media and five nonISP
media and the results are tabulated in Table 1. It exhibited
good growth on ISP 2, ISP 4, ISP 6, Bennett’s Agar, and
SC Agar, while it was moderate on ISP 1, ISP 3, ISP 5,
NAM, CD, and GT agar media. Growth was found to be
less on ISP 7. No pigment production was observed in any
of the media. Color of aerial and substrate mycelium ran-
ged from dark brown to light brown. Aerial mycelium was
white on NAM and CD agar media. Micromorphological
studies of the strain through slide culture technique and
Scanning Electron Microscopy (SEM) revealed the for-
mation of short rods by the fragmentation of hyphae in
their growth phase (Fig. 1).
According to Kampfer et al. (1991), physiological tests
play a significant role in the classification and identification
of actinobacteria. The strain exhibited good growth with
glucose, lactose, starch, and sucrose as carbon sources,
while it was moderate with maltose and fructose compared
to arabinose, D-galactose, glycerol, mannitol, raffinose, and
xylose. It exhibited good growth with organic nitrogen
sources like yeast extract and tryptone followed by peptone
and L-asparagine. Inorganic nitrogen sources like sodium
nitrate, potassium nitrate, and ammonium nitrate did not
support the growth. The isolate was indole and methyl red
positive. It showed negative results for Voges Proskauer
and citrate utilization tests (Table 2). The comparison of











ISP-1 Moderate Brown Brown –
ISP-2 Good Light brown Light brown –
ISP-3 Moderate Light brown Light brown –
ISP-4 Good Light brown Light brown –
ISP-5 Moderate Brown Dark brown –
ISP-6 Good Brown Dark brown –
ISP-7 Poor Light brown Brown –
NAM Moderate White Brown –
CD agar Moderate White Brown –
Benett’s agar Good Brown Dark brown –
GT agar Moderate Light brown Brown –
SC agar Good Brown Dark brown –
NAM nutrient agar medium, GT agar glucose–tryptone agar, CD agar
Czapek–Dox agar, SC agar starch casein agar
Fig. 1 Scanning electron
microscopic photograph of the
actinobacterial strain VLD 10
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biochemical and morphological characteristics of the strain
with those reported in Bergey’s Manual of Systematic
Bacteriology (Buchannar and Gibbons 1974) revealed its
identity as Rhodococcus sp.
The strain exhibited good growth in the medium
amended with 7–8% (w/v) NaCl, while growth was mod-
erate between 1 and 6% (w/v). No growth was found in the
medium without NaCl indicating its halophilic nature. It
could produce a broad range of commercially important
enzymes like amylase, cellulase, chitinase, L-asparaginase,
protease, and pectinase, but it was negative for DNase,
RNase, keratinase, and nitrate reductase. It was found to be
sensitive to antibiotics, such as ampicillin, chlorampheni-
col, neomycin, penicillin, rifampicin, and tetracycline, but
showed resistance to gentamicin, streptomycin, and van-
comycin (Table 2).
Using 16S rRNA analysis, the gene sequence of the
strain was compared and aligned with those sequences
retrieved from NCBI GenBank database using the BLAST
analysis. The phylogenetic tree was constructed by neigh-
bour-joining method using the MEGA software (Fig. 2)
and deposited in the Gene Bank with an accession number
KC505180. Based on these cultural, morphological, phys-
iological, and molecular analyses, the strain VLD-10 was
identified as Rhodococcus sp. VLD-10 belonging to the
family Corynebacteriaceae.
Isolation and purification of bioactive compounds
from crude extract
For the isolation and purification of bioactive compounds,
crude extract was applied on a silica gel G column
(80 9 2.5 cm, Silica gel, Merck, Mumbai, India) and their
separation was conducted via gradient elution with hexane:
ethyl acetate. Elutions were collected sequentially in small
test tubes and those fractions having similar retention
factors (Rf) on thin-layer chromatography (TLC) silica gel
plates were pooled together. Out of 11 eluted main
Table 2 Physiological and biochemical characteristics of the strain
VLD 10
Inference

























































P positive, N negative, S sensitive, R resistant
??? good growth, ?? moderate growth, ? weak growth, - no
growth
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fractions, 10 are polar residues and 1 is nonpolar residue.
Among the ten polar fractions, three fractions and the
single nonpolar fraction exhibited high antimicrobial
activity. These four fractions, namely D1, D2, D3, and D4,
were collected at different eluent systems of hexane: ethyl
acetate solvent systems, viz., 70–30 v/v, 30–70 v/v, 20–80
v/v, and 100–0 v/v, respectively. All the fractions were
rechromatographed using different gradient eluent systems
to obtain the fractions in pure form for structural elucida-
tion. The flowchart showing the isolation and purification
of bioactive fractions is illustrated in Fig S1.
Physico-chemical properties and structural
elucidation of six bioactive compounds
D1 fraction was rechromatographed into two pure frac-
tions, (D1Ba) and (D1Bb). The fraction D1Ba appeared as
yellow solid which was soluble in CHCl3, MeOH, DCM,
and DMSO. The IR absorption maxima Vmax at 1686 cm
-1
suggested the presence of functional groups like carbonyl
groups (Fig. S2a). In ESIMS, the compound showed
molecular ions at m/z = 123 [M?] inferring the molecular
weight of C7H6O2 [M]
? (Fig. S2b). The proton NMR of the
compound displayed proton signals at signals at d
8.12–8.15 (m, 2H), 7.59–7.62 (m, 1H), and 7.44–7.46 (m,
2H) due to five aromatic protons (Fig. S2c). 13C NMR
depicted peak and showed signal at d 172.7 for carbonyl
group (Fig. S2d). Based on these spectral data, the first
active fraction (D1Ba) was identified as benzoic acid.
D1Bb fraction soluble in MeOH, DCM, and DMSO
appeared as white crystalline powder. The IR absorption
maxima Vmax at 1705 cm
-1 suggested the presence of
functional aldehyde (Fig. S3a). In ESIMS, the compound
showed molecular ions at m/z = 301[2M-1] inferring the
molecular weight of 2(C7H5O3N)-1 [2M-1] (Fig. S3b). The
proton NMR of the compound displayed proton signals at d
10.43 (1H, s), and one proton for aldehyde, at d 8.13 (d,
1H, J = 7.7, 1.3 Hz), 7.96 (dd, 1H, J = 7.3, 1.9 Hz), and
7.75–7.83 (2H, m) for four aromatic protons (Fig. S3c). 13C
NMR depicted peaks at d (188.1) for aldehyde carbon
(Fig. S3d). Based on the spectral data, the fraction D1Bb
was identified as 2-nitrobenzaldehyde.
D2 fraction was rechromatographed into two pure
fractions, (D2Ba) and (D2Bb). D2Ba fraction appeared as
white crystalline powder and was soluble in CHCl3,
MeOH, and DCM. The IR absorption maxima Vmax at
Table 3 Minimum inhibitory concentration (MIC) of the bioactive compounds produced by Rhodococcus sp. VLD10
Test organism MIC (lg/ml)




Bacillus cereus 20 40 35 35 20 10 15
Bacillus megaterium 45 35 45 55 20 15 25
Bacillus subtilis 35 20 20 20 15 10 20
Corynebacterium diphtheriae 30 45 55 55 20 10 30
Escherichia coli 30 35 45 35 25 10 20
Pseudomonas aeruginosa 40 45 35 40 45 10 40
Salmonella typhi 50 50 45 45 50 20 45
Serratia marcescens 30 35 30 35 25 10 25
Shigella flexneri 35 20 20 15 25 15 15
Staphylococcus aureus 25 25 15 15 30 10 20
Xanthomonas campestris 25 35 25 20 25 10 25
Fungi
Aspergillus niger 50 85 95 70 50 20 5
Botrytis cinerea 25 80 90 75 45 15 10
Candida albicans 55 95 100 90 40 15 10
Fusarium oxysporum 50 80 70 65 35 20 10
Fusarium solani 35 100 80 65 40 20 10
Verticillium alboatrum 80 90 80 70 55 20 10
Alternaria alternata 65 75 75 85 40 20 5
Tetracylcline is the positive control for bacteria and Nystatin for fungi
5D1Ba benzoic acid, D2Ba 4-chlorobenzaldehyde, D1Bb 2-nitrobenzaldehyde, D2Bb nonadeconoic acid, D3 3-isopropylhexahydro-1H-pyr-
ido[1,2-a] pyrazine-1,4(6H)-dione
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1683 cm-1 suggested the presence of aldehyde (Fig. S4a).
In ESIMS, the compound showed molecular ions at m/
z = 141 [M?1]? inferring the molecular weight of C7H6-
OCl [M?1]? (Fig. S4b). The proton NMR of the com-
pound displayed proton signals at d 9.99 (s, 1H) for one
aldehyde proton, and at d 7.83 (d, 2H, J = 8.5 Hz) and
7.53 (d, 2H, J = 8.5 Hz) for four aromatic protons
(Fig. S4c). 13C NMR depicted peak at d 190.7 for aldehyde
(Fig. S4d). D2Ba was identified as 4-chlorobenzaldehyde
based on the spectral data.
The second fraction D2Bb in pure form appeared as
light green liquid soluble in CHCl3, MeOH, DCM, and
DMSO. The IR absorption maxima Vmax at 1709 cm
-1
suggested the presence of carboxylic group (Fig. S5a). In
ESIMS, the compound showed molecular ions at m/
z = 299 [M?1]? inferring the molecular weight of
C19H38O2 [M?1]
? (Fig. S5b). The proton NMR of the
compound displayed at d 2.35 (t, 2H, J = 7.2 Hz) for alpha
methylene protons; at d 1.65–1.55 (30H, m) and 1.25–1.99
(m, 2H) for aliphatic methylene protons; at d 1.25–1.99 (m,
2H) for methylene protons; and at d 0.82 (t, 3H,
J = 6.1 Hz) for methyl protons (Fig. S5c). 13C NMR
depicted peak at d 180.8 for carboxylic group (Fig. S5d).
Based on spectral data, the D2Bb fraction was identified as
nonadeconoic acid.
Fraction D3 appeared as white solid, which was soluble
in CHCl3, MeOH, DCM, and DMSO. The IR absorption
maxima Vmax at 1687 cm
-1 suggested the presence of
functional groups like carbonyl group (Fig. S6a). In
ESIMS, the compound showed molecular ions at m/
z = 211.1474 [M?1] inferring the molecular weight of
C11H1902N2[M?1]
? (Fig. S6b). The proton NMR of the
compound displayed proton signals at d 5.91 (s, 1H) for
amide protons; 4.12 (t, 1H, J = 7.5 Hz) for methylene
protons; 4.02 (d, 1H, J = 6.7 Hz) for methylene protons;
3.67–3.48 (m, 2H) for methylene protons; 2.45–2.24 (m,
1H) and 2.23–1.97 (m, 3H) for methylene proton;
1.96–1.83 (m, 1H), 1.82–1.69 (m,1H), and 1.60–1.45 (m,
1H) for methylene protons; and 1.05 (d, 3H, J = 6.0 Hz)
and 0.96 (d, 3H, J = 6.0 Hz) for methyl protons.
(Fig. S6c). 13C NMR depicted peaks at d 170.2 (1C), 166.1
(1C), 76.5 (1C), 58.9 (1C), 53.3 (1C), 45.4 (1C), 38.5 (1C),
29.6 (1C), 28.0 (1C), 24.6 (1C), 23.2 (1C), 22.7 (1C), and
at d 21.1 (1C) (Fig. S6d). DEPT spectrum exhibiting
methyl groups (12, 121), methylene groups (3, 4, 5, 10),
and methylene groups (6, 9, 11) (Fig. S6e). 1H–1H COSY
NMR spectrum exhibits correlation between H12–H11, H10–
H11, H10–H9, H6–H5, H5–H4, H4–H3 (Fig. S6f). HSQC
spectrum exhibits correlation between 13 C NMR with 1H
NMR: C3–H3, C4–H4, C5–H5, C6–H6, C9–H9, C10–H10,
C11–H11, C12–H12, and C13–H13 (Fig. S6g). HMBC spec-
trum exhibits following correlation of 13 C NMR with 1H
NMR 23.2–1.05; 21.1–0.96; 24.6–1.55; 38.5–1.55, 2.08;
53.3–4.03; 58.9–4.15; 28.0–2.18, 2.38; 22.7–1.97, 2.05;
45.4–3.60; 170–4.12; and 166.1–4.02. (Fig. S6h). Based on
these spectral data, the active fraction D3 was identified as
Fig. 2 Phylogenetic tree of
16SrRNA sequence of the
actinobacterial strain VLD 10
constructed in comparison with
those of species of genus
Rhodococcus using neighbour-
joining method. Bar, one
substitutions per nucleotide
position
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3-isobutylhexahydropyrrolo[1,2-a]pyrazine-1,4-dione This
is the first report from actinobacteria.
Determination of MIC of the isolated bioactive
compounds
MIC of the bioactive compounds, viz., benzoic acid,
2-nitrobenzaldehyde, 4-chlorobenzaldehyde, nonadeconoic
acid, and 3-isopropylhexahydro-1H-pyrido[1,2-a] pyr-
azine-1,4(6H)-dione (Fig. 3), along with crude extract of
the strain VLD-10 against bacteria and fungi was deter-
mined. The sensitivity of bacteria as well as fungi to the
compounds exhibited variation and the MIC of these
compounds ranged from 5–100 lg/ml (Table 3). Bioactive
compounds of the crude extract showed good antimicrobial
activity against test bacteria and fungi in the range of
10–20 lg/ml. Benzoic acid (D1Ba) is active against bac-
teria, such as B. cereus, S. aureus, and X. campestris as
compared to the other bacteria tested, while Botrytis
cinerea is sensitive among fungi. 2-nitrobenzal dehyde
(D1Bb) is mostly active against bacteria like B. subtilis,
Shigella flexneri, and Staphylococcus aureus.
4-chlorobenzaldehyde (D2Ba) is active against S. aureus,
B. subtilis, and S. flexneri. Nonadeconoic acid (D2Bb) is
active against S. flexneri, S. aureus, B. subtilis, and X.
campestris. Among all the compounds, 3-isopropylhex-
ahydro-1H-pyrido[1,2-a] pyrazine-1,4(6H)-dione (D3) is
more active against B. subtilis, B. cereus, B. megaterium,
C. diphtheriae, and E. coli, but it showed less activity
against the fungi when compared to that of standard control
(nystatin). The partially purified fraction (D4) exhibited
good activity against Bacillus spp. tested.
Rhodococci are notable for the ability to degrade a
variety of natural and xenobiotic compounds (Bell et al.
1998) along with few bioactive metabolite reports. Chiba
et al. (1999) purified and elucidated a novel antifungal
cyclic tetrapeptide, Rhodopeptins (Mer-N1033) from
Rhodococcus sp. Two antimycobacterial agents, lariatins A
and B, were elucidated by Iwatsuki et al. (2006) from the
culture broth of Rhodococcus sp. K01-B0171 using spec-
tral analysis and advanced protein chemical methods.
Kitagawa and Tamura (2008) isolated a new quinoline
antibiotic, aurachin RE from the culture broth of
Rhodococcus erythropolis JCM 6824 active against both
high- and low-GC Gram-positive bacteria.
Isolation and purification of rhodostreptomycin A and B
by a combination of cation exchange (CM-Sephadex) and
reversed-phase HPLC (Lichrospher 60RP-select B) from
the culture broths of Rhodococcus fascians 307CO were
recorded (Kurosawa et al. 2008). Abdel-Meged et al.
(2011) purified, characterized, and tested the antimicrobial
activity of glycolipids produced by Rhodococcus erythro-
polis isolated from soils of Riyadh area, Saudi Arabia.
Borisova (2011) found that antimicrobial compound (MW
911.5452 Da) of Rhodococcus opacus isolated from the
soils of East Tennessee State University inhibited R. ery-
thropolis and a large number of closely related species.
This study has revealed the production of five bioactive
compounds, such as benzoic acid, 2-nitrobenzaldehyde,
4-chlorobenzaldehyde, nonadeconoic acid, and 3-iso-
propylhexahydro-1H-pyrido[1,2-a] pyrazine-1,4(6H)-
dione, from Rhodococcus sp. VLD-10. Benzoic acid is a
well-known food preservative that inhibits the growth of
bacteria, yeasts, and molds (Warth 1991), which is also















Fig. 3 a Molecular structure of benzoic acid, b molecular structure
of 2-nitrobenzaldehyde, c molecular structure of 4-chlorobenzalde-
hyde, d Molecular structure of nonadeconoic acid, and e molecular
structure of 3-isopropylhexahydro-1H-pyrido[1,2-a] pyrazine-
1,4(6H)-dione
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compounds, 2-nitrobenzaldehyde and 4-chlorobenzalde-
hyde play a prominent role in the manufacture of phar-
maceuticals, dyes, agrochemicals, and other organic
compounds. However, their natural occurrence from
Rhodococcus spp. and their biological significance is not
yet reported. This is the first report of 3-isopropylhexahy-
dro-1H-pyrido[1,2-a] pyrazine-1,4(6H)-dione isolated from
Rhodococcus sp. VLD-10.
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